Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
abscess, intracranial-fungal
addiction, heroin
amphotericin B
amyloidosis
anesthesia, epidural
aneurysm, vertebral basilar system
arm weakness
arteriopathy
aspergillosis
autoimmune meningitis
basilar artery
basilar artery occlusion
beta-D-glucon
brain biopsy
brain biopsy, false negative
brain biopsy, indication
brainstem, infarction of
BUN, elevated
candida albicans
CAT scan, abnormal
CD4 counts
cerebrospinal fluid, beta-D-glucan
cerebrospinal fluid, culture negative
cerebrospinal fluid, elevated protein of
cerebrospinal fluid, gram stain of
cerebrovascular accident
chemical meningitis
chest x-ray, abnormal
Clinical Pathologic Conference(C.P.C.)
cognition
complications
cranial nerve enhancement
cranial neuropathy
creatinine, elevated
cryptococcal meningitis
dementia
dementia, rapidly progressive
diplopia
drug abuse
dysarthria
exome sequencing
facial asymmetry
facial weakness
false negative
fever
fourth ventricle, compression
fungal infection
fungal infection, CNS
fungal infection, CNS, treatment of
fusiarum solani meningitis
gait disorder
gram positive cocci
headache
headache, awakening with
headache, positional
headache, progressive
hearing loss
hemiparesis
hepatitis C virus
hydrocephalus
hydrocephalus, non-communicating(obstructive)
hypoglycorrhachia
iatrogenic neurologic disorders
idiopathic CD4+lymphopenia
imbalance
immunocompetent
immunosuppression
intravenous drug abuse
lethargy
lymphopenia
meningeal enhancement
meningitis
meningitis, aseptic
meningitis, bacterial
meningitis, basilar
meningitis, candida
meningitis, carcinomatous
meningitis, chronic
meningitis, fungal
meningitis, helminthic
meningitis, iatrogenic
meningitis, neutrophilic
meningitis, noninfectious
meningitis, parameningeal
meningitis, parasitic
meningitis, spinal fluid smear and culture-negative
meningitis, TB
meningitis, treatment of
meningitis, treatment of, empirical
meningitis, viral etiology in
meningitis-encephalitis PCR panel
mental status, abnormal
metabolic acidosis
Mexico
misdiagnosis
mortality
MRI, abnormal
MRI, contrast enhanced
MRI, mass effect on
MRI, nodular enhancement
MRI, ring sign
MRI, target sign
mucormycosis
nausea and vomiting
needle tracks
neurologic disease, diagnoses of
neuropathology
next-generation sequencing
normal
nosocomial infection
opportunistic infection
opportunistic infection, CNS
papilledema
phonophobia
photophobia
pleocytosis of cerebrospinal fluid
pleocytosis of cerebrospinal fluid, neutrophilic
pneumonia
polymerase chain reaction
posterior circulation stroke
prognosis
proteinuria
renal biopsy
renal failure
review article
sarcoidosis, CNS
seizure
shunt procedure, ventricular
shunt procedure, ventricular-complications of
speech, slowed
splenomegaly
strokelike episodes
systemic illness
tinnitus
treatment of neurologic disorder
vasculopathy
vision, blurred
visual loss, transient
visual obscurations, transient
Showing articles 250 to 300 of 406 << Previous Next >>

Interferons in the Treatment of Multiple Sclerosis,Do They Prevent the Progression of the Disease?
Arch Neurol 55:1578-1580,1583, Rice,G.&Ebers,G, 1998

Interferons Should be Used to Treat Most Patients with MS
Arch Neurol 55:1581-1583, Herndon,R.M.&Jacobs,L, 1998

Randomised Double-Blind Placebo-Controlled Study of Interferon B-1a in Relapsing/Remitting Multiple Sclerosis
Lancet 352:1498-1504,1486, PRISMS, 1998

Placebo-Controlled Multicentre Randomised Trial of Interferon B-1b in Treatment of Secondary Progressive Multiple Sclerosis
Lancet 352:1491-1497,1486, European Study Group on Interferon B-1b in Seconda, 1998

Effect of Steroids on Gd-Enhancing Lesions Before & During Beta Interferon 1a Trtm in Relapsing Remitting MS
Neurol 50:403-406, Gasperini,C.,et al, 1998

Interferon Treatment for Multiple Sclerosis:Autoimmune Complications May be Lethal
Neurol 50:570-571, Durelli,L.,et al, 1998

Anhidrosis:An Unusual Presentation of Diabetes Insipidus
Neurol 49:1708-1710, Shimizu,H.,et al, 1997

The Quality-of-Life Effects of Interferon Beta-1b in MS
Arch Neurol 54:1475-1480, Schwartz,C.E.,et al, 1997

Management of Multiple Sclerosis
NEJM 337:1604-1611, Rudick,R.A.,et al, 1997

Drugs and Myasthenia Gravis, An Update
Arch Int Med 157:399-408, Wittbrodt,E.T., 1997

Character of MRI Response to Trtm with Interferon Beta-1B:Enhancing MRI Lesion Freq as Prim Outcome Measure
Neurol 49:862-869, Stone,L.A.,et al, 1997

Impact of Interferon Beta-1A On Neurologic Disability in Relapsing Multiple Sclerosis
Neurol 49:358-363, Rudick,R.A.,et al, 1997

A Comparison of Divalproex with Propranolol and Placebo for the Prophylaxis of Migraine Without Aura
Arch Neurol 54:1141-1145, Kaniecki,R.G., 1997

Management of Patients Receiving Interferon Beta-1b for MS:Report of a Consensus Conf
Neurol 46:12-18, Lublin,F.D.,et al, 1996

Side Effect Profile of Interferon Beta-1b in MS:Results of an Open Label Trial
Neurol 46:552-554, Neilley,L.K.,et al, 1996

Vitamin D Deficiency and Osteopenia in Hemiplegic Limbs of Stroke Patients
Stroke 27:2183-2187, Sato,Y.,et al, 1996

Electromagnetic Field Exposure May Cause Increased Production of Amyloid Beta & Eventually lead to Alzheimer's Disease
Neurol 47:1594-1600, Sobel,E.&Davanipour,Z., 1996

Neutralizing Antibodies During Treatment of Multiple Sclerosis with Interferon Beta-1b
IFNB MS Study Group & UBC MS. MRI Analysis Group, Neurol 47:889-8946., , 1996

Guidelines for Physicians with Patients on IFNB-1b:The Use of an Assay for Neutralizing Antibodies (NAB)
Neurol 47:865-866, Paty,D.,et al, 1996

Interferon Beta in Multiple Sclerosis
BMJ 313:1159, 1157, 1195996., Richards,R.G., 1996

Image Analysis of B-Amyloid Load in Alzheimer's Disease and Relation to Dementia Severity
Lancet 346:1524-1528, Cummings,B.J.&Cotman,C.W., 1995

Apolipoprotein E, Dementia, and Cortical Deposition of B-Amyloid Protein
NEJM 333:1242-1247, 12831995., Polvikoski,T.,et al, 1995

Is Neurally Mediated Hypotension an Unrecognized Cause of Chronic Fatigue?
Lancet 345:623-624, Rowe,P.C.,et al, 1995

Severe Necrotizing Cutaneous Lesions Complicating Treatment with Interferon Beta-1b
NEJM 332:1584, Sheremata,W.A.,et al, 1995

The Interferons:Biological Effects, Mechanisms of Action, and Use in Multiple Sclerosis
Ann Neurol 37:7-15, Weinstock-Guttman,B.,et al, 1995

Management of the Behavioral Manifestations of Dementia
Arch Int Med 155:250-260, Yeager,B.F.,et al, 1995

Drugs for Migraine
The Medical Letter 37:17-20, , 1995

Interferon Beta-1b in the Trtm of MS:Outcome of the Randomized Controlled Trial
IFNB Study Gr, Neurol 45:1277-12851995., , 1995

Effect of Interferon-B on Blood-Brain Barrier Disrupt Demonst by Contrast MRI in Relapsing-Remitting MS
Ann Neurol 37:611-619, Stone,L.A.,et al, 1995

Betaseron for Multiple Sclerosis:Implications for Therapeutics
Arch Neurol 51:125-128, Rudick,R., 1994

Excitatory Amino Acids as a Final Common Pathway for Neurologic Disorders
NEJM 330:613-622, Lipton,S.A.&Rosenberg,P.A., 1994

A Controlled Trial of Riluzole in Amyotrophic Lateral Sclerosis
NEJM 330:585-591, Bensimon,G.,et al, 1994

Tilt-Talbe Testing and Oral Metoprolol Therapy in Young Patients with Unexplained Syncope
pediatrics 93:278-283, O'Marcaigh,A.S.,et al, 1994

The Prolonged QT Syndrome Presenting as Epilepsy:A Report of Two Cases and Literature Review
Neurol 44:1408-1410, Pacia,S.V.,et al, 1994

Practice Advisory on Selection of Patients with Multiple Sclerosis for Treatment with Betaseron
Neurol 44:1537-1540, Alter,M.,et al, 1994

Are Magnetic Resonance Findings Pred of Clinical Outcome in Therapeutic Trials in MS? The Dilemma of Interferon-B
Ann Neurol 36:14-18, McDonald,W.I.,et al, 1994

The Relationship of Essential Tremor to Other Movement Disorders:Report on 678 Patients
Ann Neurol 35, 717-7231994., Koller,W.C.,et al, 1994

Human Prion Diseases
Ann Neurol 35:385-395, Prusiner,S.B.&Hsiao,K.K., 1994

Parkinsonism Unmasked by Verapamil
Clinical Neuropharmacol 16:263-265, Garcia-Albea,E.,et al, 1993

Brief Report:Treatment of Vasospastic Amaurosis Fugax with Calcium-Channel Blockers
NEJM 329:396-398, 4261993., Winterkorn,J.M.S.,et al, 1993

Trial of Secondary Prevention with Atenolol after Transient Ischemic Attack or Nondisabl Ischemic Stroke
Dutch TIA Study Group, Stroke 24:543-5481993., , 1993

Interferon Beta-1b is Effective in Relapsing-Remitting MS
Clinical Results of a Placebo-Controlled Trial, IFNB MS Study Grp, Neurol 43:655-661, 64193., , 1993

Interferon Beta-1b is Effective in Relapsing Remitting MS, MRI Analysis Results of Placebo-Control Trial
Neurol 43:662-667, 6411993., Paty,D.W.,et al, 1993

Recurrent Migraine and Intravenous Immune Globulin Therapy
NEJM 329:583-584, Constantinescu,C.S.,et al, 1993

Neurologist's Role in Understanding Violence
Arch Neurol 50:867-871, Pincus,J.H., 1993

Propranolol and Amitriptyline in Prophylaxis of Migraine, Pharmacokinetic and Therapeutic Effects
Arch Neurol 50:825-830, Ziegler,D.K.,et al, 1993

Clinicopath Conf
Spongiform Encephalopathy (Creutzfeldt-Jakob Disease) , with Amyloid (KURU) Plaques, Case 17-1993, N, JM 328:66,1993., 1993

Comparison of Cardiac Pacing with Drugs in Treat of Neurocard (Vasovagal Syncope with Bradycardia/Asystole
NEJM 328:1085-1090, 11171993., Sra,J.S.,et al, 1993

DDAVP in the Management of Nocturia in Multiple Sclerosis
Ann Neurol 31:577, Valiquette,G.,et al, 1992

Atenolol Compared with Nifedipine:Effect on Cognitive Function and Mood in Elderly Hypertensive Patients
Ann Int Med 116:615-623, Skinner,M.H.,et al, 1992



Showing articles 250 to 300 of 406 << Previous Next >>